Development of generic gliclazide 60 mg modified release tablets using central composite design
A modified release gliclazide 60 mg tablet using Methocel® K100 Premium LV DC2 as a drug retaining polymer was prepared by direct compression. Central composite design was adopted for formulation optimization. The two independent formulation variables included the amount of Methocel® K100 LV DC2...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacists of Buenos Aires Province, Argentina
2015
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/44848/1/Latin_American_Journal_of_Pharmacy_34_8_page_1516.pdf http://irep.iium.edu.my/44848/ http://www.latamjpharm.org/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!